-
two clinical studies in Kenya and Zambia, assessing whether E. coli carriage contributes to Enterobacteriaceae colonization and ARG transmission. Finally, the PhD student will use agent-based modeling
-
liquid biomarkers for leukodystrophies by integrating multi-omics data from patient plasma and iPSC-derived human disease models. You will investigate disease-related molecular signatures using
-
diagnosis, monitor disease progression and assess treatment response. In this PhD project, you will develop and validate liquid biomarkers for leukodystrophies by integrating multi-omics data from patient
-
embedded within the Quantitative Healthcare Analysis (qurAI) group and conducted in close collaboration with the CARA Lab and clinical partners in the Netherlands and abroad. You will work with large, multi
-
will independently contribute to the design and implementation of a multi-site, international research project. Your work will include qualitative and quantitative research, development and validation
-
partners in the Netherlands and abroad. You will work with large, multi-center clinical datasets and contribute to translating advanced computational methods into clinically relevant applications. This PhD
-
, with academic enrolment through the Eberhard Karls University of Tübingen. You will pursue a PhD in a relevant discipline. You will independently contribute to the design and implementation of a multi